Comparative study of transurethral 2 μm thulium laser resection vs. standard transurethral electroresection in treating high grade non-muscle-invasive bladder cancer
Cui Xin1, Li Jin1, Wang Qi1, He xinzhou1, Ou Tongwen1,
1Urology of Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Abstract：Objective: To compare the efficacy and safety of 2 μm thulium laser with transurethral resection of bladder tumor (TURBT) in the treatment of high grade non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed 110 patients with high grade NMIBC, who were divided into 2 μm laser (n=62) and TURBT groups (n=48) from January 2009 to June 2012. The patients of two groups received reoperation after 4 to 6 weeks. The operation time, complications, reoperation biopsy, postoperative gross hematuria and hospital stay were compared between the two groups. Results: Compared to TURBT group, 2 μm laser group showed significantly lower rate of complications and recurrence, less postoperative gross hematuria, and shorter postoperative hospital stay (P<0.05). Conclusions: 2 μm thulium laser is safe and effective for patients with NMIBC. The approach has less complications than TURBT.
崔昕,李进,王琦,何新州,欧彤文. 2 μm激光与经尿道膀胱肿瘤切除术治疗高级别非肌层浸润性膀胱癌的对比研究[J]. 微创泌尿外科杂志, 2015, 4(3): 146-149.
Cui Xin, Li Jin, Wang Qi, He xinzhou, Ou Tongwen,. Comparative study of transurethral 2 μm thulium laser resection vs. standard transurethral electroresection in treating high grade non-muscle-invasive bladder cancer. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2015, 4(3): 146-149.
[1]Babjuk M. Transurethral resection of non-muscle-invasive bladder cancer. Eur Urol Suppl, 2009,8(7):542-548. [2]那彦群,叶章群,孙光.中国泌尿外科疾病诊断治疗指南2011版.北京:人民卫生出版社,2011:21-29 [3]Van Rhijn BW, Burger M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol, 2009,56(3):430-442. [4]Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol, 2001,19(3):666-675. [5]Gupta A, Lotan Y, Bastian PJ, et al. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology, 2008,71(2):302-307. [6]Thalmann GN, Markwalder R, Shahin O, et al. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol, 2004,172(1):70-75. [7]Shelley MD, Court JB, Kynaston H, et al. Intravesical bacillus Calmette-Guerin in Ta and T1 bladder cancer. Cochrane Database Syst Rev, 2000,(4):CD001986. [8]夏术阶,于胜强.激光技术在泌尿系统肿瘤治疗中的合理应用.现代泌尿外科杂志,2007,12(4):211-213. [9]Zhu Y, Jiang X, Zhang J, et al. Safety and efficiency of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology, 2008,72(3):608-612. [10]Zhong C, Guo S, Tang Y, et al. Clinical observation on 2 micron for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol, 2012,28(2):157-161. [11]Liu H, Xue S, Ruan Y, et al. 2-micrometer continuous wave laser treatment for multiple non-muscle-invasive bladder cancer with intravesical instillation of epirubicin. Laser Surg Med, 2011,43(1):15-20. [12]Yang Y, Wei ZT, Zhang X, et al. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol, 2009,182(1):66-69. [13]Herrmann TR, Liatsukos EN, Nagele U, et al. EAU guidelines on laser technologies. Eur Urol, 2012,61(4):783-795. [14]Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumor specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol, 2010,57(5):843-849.
